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We combine a genome-scale RNAi screen in mouse
epiblast stem cells (EpiSCs) with genetic interaction,
protein localization, and ‘‘protein-level dependency’’
studies—a systematic technique that uncovers post-
transcriptional regulation—to delineate the network
of factors that control the expression of Oct4, a key
regulator of pluripotency. Our data signify that there
are similarities, but also fundamental differences in
Oct4 regulation in EpiSCs versus embryonic stem
cells (ESCs). Through multiparametric data analyses,
we predict that Tox4 is associating with the Paf1C
complex, which maintains cell identity in both cell
types, and validate that this protein-protein interac-
tion exists in ESCs and EpiSCs. We also identify
numerous knockdowns that increase Oct4 expres-
sion in EpiSCs, indicating that, in stark contrast to
ESCs, Oct4 is under active repressive control in
EpiSCs. These studies provide a framework for
better understanding pluripotency and for dissecting
the molecular events that govern the transition
from the pre-implantation to the post-implantation
state.
INTRODUCTION
The ability to culture stem cells isolated from early mammalian
embryos in vitro, exemplified by mouse embryonic stem cells
(ESCs) and the developmentally more advanced epiblast stem
cells (EpiSCs), has greatly expanded our knowledge about
development and has fueled the field of regenerative medicine
(ten Berge et al., 2011). Like ESCs, EpiSCs are pluripotent cells
that can give rise to cells of the three germ layers: ectoderm,
mesoderm, and endoderm. EpiSCs recapitulate properties of
the post-implantation epiblast (Brons et al., 2007; Tesar et al.,
2007) and can be propagated indefinitely in vitro. Consequently,they are uniquely positioned to provide insights into the develop-
mental window when somatic and germ cell lineages are first
established (Chenoweth et al., 2010). Global gene expression
analysis from ESCs and EpiSCs shows that EpiSCs express
some of the pluripotency transcription factors (TFs) known to
drive self-renewal in ESCs. However, the overall expression
pattern of EpiSCs is quite distinct from ESCs (Brons et al.,
2007; Tesar et al., 2007). Furthermore, the culture conditions
for maintaining the two cell types are different. While ESC self-
renewal depends on LIF-Stat3 signaling, EpiSCs require Activin
and Fgf signaling for maintaining an undifferentiated state (Brons
et al., 2007; Tesar et al., 2007) (Figure 1A).
ESC pluripotency is regulated by a complex orchestration of
TFs, transcriptional coactivators, epigenetic regulators, miR-
NAs, and extracellular signals. Several TFs, including Oct4
(also called Pou5f1), Nanog, and Sox2, form the core transcrip-
tional circuitry in the maintenance of pluripotent ESCs (Boyer
et al., 2005). Oct4, Nanog, and Sox2 are also expressed in
EpiSCs. However, many additional TFs that are important for
ESC identity and that are vital components of the core circuitry,
such as Tbx3 or Esrrb, are not expressed in EpiSCs (Brons et al.,
2007; Tesar et al., 2007), signifying the relatedness but also the
distinction between EpiSCs and ESCs. Oct4 is critically involved
in maintaining pluripotency in both cell types. Accordingly,
changing its expression level causes differentiation of EpiSCs
(Chenoweth et al., 2010). Hence, Oct4 expression is a valuable
reporter for the status of pluripotent cells.
In the past few years, a number of RNA interference (RNAi)
screens have been performed in mouse ESCs (reviewed in
Ding et al., 2012). Results of these screens have greatly
extended our knowledge of ESC biology and have led to the
identification of novel components required to maintain ESC
identity. Importantly, these screens have also provided new in-
sights into understanding the interplay of multiple pathways of
TFs, epigenetic regulators, and cellular signals implicated in
ESC pluripotency (Ding et al., 2012).
Much less is known about the genes and pathways that regu-
late EpiSCs, and comprehensive functional screens in EpiSCs
have not been reported. To gain a systematic understanding of
the genes associated with EpiSC identity, we performed fourCell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc. 141
Figure 1. Genome-Scale RNAi Screen in
Mouse EpiSCs
(A) Illustration of important shared and divergent
attributes in ESCs and EpiSCs. Genes for exem-
plified indicated classes and pathways are shown.
The GSK-3 inhibitor (CHIR99021) and MEK inhib-
itor (PD0325901) that maintain self-renewal of
ESCs are indicated.
(B) Comparative analysis of the screen results in
EpiSCs and in ESCs. The y axis represents the
average Z scores for the GFP intensity for each
targeted gene. Upregulated (Z score >2) or
downregulated (Z score <2) Oct4 expression is
depicted in yellow and blue, respectively. Note the
large number of knockdowns that upregulated
Oct4 expression in the EpiSCs screen.large-scale analyses in mouse EpiSCs: a genome-scale RNAi
screen, genetic interaction mapping, protein localization, and
protein-level dependency (PLD, discussed below). These data
define shared and distinguishing factors in naive and primed
pluripotent cells and provide insights into the dynamics that
accompany the transitions between ESCs and EpiSCs. They
also provide one method for translating genome-wide, loss-of-
function genetic screens into specific, testable hypotheses
about how phenotypes are generated.
RESULTS
Primary RNAi Screen in EpiSCs
Numerous factors and multiple signaling pathways have been
recognized to regulate Oct4 expression in ESCs. However,
even though it is known that tightly controlled Oct4 levels are
also required to maintain EpiSC identity (Chenoweth et al.,
2010), much less is known about the factors that influence
Oct4 expression in these cells (Hackett and Surani, 2014; Mar-
tello and Smith, 2014; Nichols and Smith, 2009) (Figure 1A). To
fill this gap, we set out to identify Oct4 regulators in EpiSCs.
The mouse EpiSCs line OE7, derived from embryos that express
GFP from Oct4 regulatory elements (Ying et al., 2002), was used
for the screen. An equivalent Oct4-GFP reporter line (Oct4-GiP)
has previously been used to identify Oct4 regulators in ESCs
(Ding et al., 2009; Hu et al., 2009). GFP fluorescence intensity re-
flects the Oct4 levels in individual OE7 EpiSCs and thus can be142 Cell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc.used as a rapid and accurate readout
via fluorescence-activated cell sorting
(FACS).
To investigate the feasibility of an RNAi
screen in EpiSCs, first we optimized cul-
ture conditions and transfection proto-
cols (see Experimental Procedures). To
evaluate whether we could accomplish
comparable knockdown efficacies in
EpiSCs, we transfected OE7 EpiSCs and
ESCs with a panel of endoribonuclease
prepared (e)siRNAs (Kittler et al., 2007)
and measured the knockdown levels by
quantitative RT-PCR (RT-qPCR) 24-hr
post-transfection. EsiRNAs are enzymat-ically prepared pools of siRNA-like molecules that have proven
efficacy and specificity in ESC and other mammalian cells
(Ding et al., 2012; Surendranath et al., 2013). EsiRNAs efficiently
and comparably downregulated all tested transcripts in ESCs
and EpiSCs (Figure S1A), suggesting that esiRNAs are well
suited silencing triggers for RNAi screens in EpiSCs.
Having established a robust esiRNA transfection protocol, we
proceeded to execute a similar high-throughput RNAi screen as
performed previously in ESCs (Ding et al., 2009). We transfected
OE7 EpiSCs in duplicate in 384-well plates and evaluated the
reliability of the screen by comparing the scores of each esiRNA.
The overall analysis revealed a Pearson correlation of 0.87, sug-
gesting high consistency between the replicates (Figure S1B). To
determine thresholds for candidate hit calling, we analyzed all
positive (Ctr9 esiRNA) and negative (non-targeting Luc esiRNA)
controls and set a Z-score threshold, where 99% Ctr9 esiRNAs
scored and 99% of the non-targeting control esiRNAs did not
score (Figure S1C).
Screen Comparison between ESCs and EpiSCs
With these criteria, we nominated 467 primary hits that down-
regulated Oct4 expression in EpiSCs (Figure 1B; Table S1).
Many known pluripotency genes that scored in ESC screens
scored significantly, including the core circuitry factors Oct4,
Nanog, and Sox2 and associated factors such as Tcf3, Sall1,
Sall4, and Zfp281, demonstrating the effectiveness of the
screen. In addition, multiple components of complexes or genes
functioning in the same pathway and that had been identified in
ESC screens scored similarly and significantly, including medi-
ator componentsMed4,Med12,Med14,Med17; Paf1C subunits
Ctr9, Rtf1, Wdr61; chromatin remodeling factors Cxxc1, Mll2,
Smarcc1, Smarce1, Ep300, Cited1, Jmjd1c, Crebbp; and Wnt
pathway component Apc (Table S1). Hence, many genes that
are important to sustain Oct4 expression in ESCs are also vital
to support Oct4 expression in EpiSCs.
Knockdowns that upregulate Oct4 expression in ESCs were
rarely seen among any of the reported RNAi screens (reviewed
in Ding et al., 2012), suggesting that repressors for Oct4 ex-
pression are rare, or not present in ESCs. In sharp contrast,
our EpiSC screen identified 149 esiRNAs that significantly upre-
gulated Oct4 expression (Figure 1B; Table S1). This result likely
reflects differences in Oct4 regulation between the two cell types
(Yeom et al., 1996) and indicates that Oct4 is under repressive
control in EpiSCs.
Validation
To investigate whether GFP fluorescence faithfully reflects Oct4
protein levels, we knocked down five genes (Apc, Med14,
Ep300, Wdr82, and Tox4) that downregulated GFP fluorescence
and five genes (Brd4, Ctnnb1, Ep400, Smc1a, and Rad21) that
upregulated GFP fluorescence in OE7 EpiSCs. At 72 hr post-
transfection, Oct4 protein was assessed by quantitative western
blot hybridization (Figure S1D). For all ten genes the western blot
quantifications of Oct4 were consistent with the FACS-based
GFP readouts, suggesting that the GFP measurements faithfully
reflect Oct4 expression.
To reduce false positives due to off-target effects, we synthe-
sized 174 independent secondary esiRNAs for the strongest hits
(77 for downregulation of Oct4 expression and 97 for upregula-
tion of Oct4 expression). The independent esiRNA transfections
validated 53 primary hits (69%) that downregulated Oct4 expres-
sion and 54 primary hits (56%) that upregulated Oct4 expression
in EpiSCs at high confidence (Figure S1E; Table S2).
Categorization of Validated Genes
To start a more detailed investigation of validated genes, we
transfected OE7 EpiSCs and the equivalent Oct4-GFP reporter
ESCs (Oct4-Gip; Ying et al., 2002) with the primary and second-
ary esiRNAs targeting 121 genes (107 validated hits and 14 addi-
tional genes from a previous ESCs screen) (Ding et al., 2009) and
measured the GFP intensities 72-hr post-transfection in quadru-
plicates (Table S3). Highly reproducible data were obtained from
these experiments with an average correlation coefficient of 0.91
and 0.88 for EpiSCs and ESCs, respectively. Knockdowns were
grouped into five categories based on their phenotypes with
respect to changes in Oct4 expression in ESCs and EpiSCs
(Figure 2A).
Many genes, including known genes associated with pluripo-
tency, such as Oct4, Sox2, Med12, Med14, Ctr9, Rtf1, Wdr61,
Cpsf3, Fip1l1, Cnot1, Cnot2, Cnot3, Tcf3, Cxxc1, Rnf2, and
Mll2, clustered in category 1 (Figure 2A), where the knockdown
reduced Oct4 levels, signifying that ESCs and EpiSCs share
common pathways to maintain pluripotency. However, about
40% of the knockdowns that resulted in reduced Oct4 expres-
sion in EpiSCs did not significantly affect its expression in
ESCs (Figure 2A, category 2). Hence, these genes representcandidates that are specifically required to maintain Oct4
expression in EpiSCs. Accordingly, this class includes the TFs
Sall1, Sall4, and Nanog, all factors that have previously been
shown to be dispensable for ESC self-renewal (Chambers
et al., 2007; Karantzali et al., 2011; Yuri et al., 2009). Our data
indicate that Oct4 expression is more dependent on these fac-
tors in EpiSCs.
Fifty-four genes led to an upregulation of Oct4 on knockdown
in EpiSCs. Interestingly, components from a recently described
Myc-centered network, a module essential to maintain ESC plu-
ripotency that is independent from the Oct4 centered core mod-
ule, fall into this category (Figure 2A, category 3). Myc, Max,
Dmap1, Tip60, Trrap, andEp400are tightly interconnectedwithin
this protein interaction network and co-occupy a large number of
promoters of target genes (Kim et al., 2010). Knockdown of Max,
Tip60, Trrap, and Ep400 resulted in marked upregulation of Oct4
expression in EpiSCs, whereas little to no change inOct4 expres-
sion was observed after knockdown in ESCs. These data sug-
gest that, in contrast to the core transcriptional module, which
serves as an activator of Oct4 expression in both ESCs and
EpiSCs, the Myc module, while important to maintain pluripo-
tency in both cell types (Fazzio et al., 2008; Kim et al., 2010), func-
tions as an Oct4 repressor specifically in EpiSCs.
Possibly the most surprising cluster is category four (Fig-
ure 2A). Here, knockdowns led to a reduced expression of
Oct4 in ESCs, while knockdowns in EpiSCs increased Oct4
expression. Interestingly, two subunits of the cohesin complex
(Rad21 and Smc1a) fall into this category (Figure 2A, category
4, and Figure 2B). Cohesin has amultitude of functions, including
a role in transcriptional regulation via chromosome organization
(Losada, 2014). Indeed, it was recently shown that cohesin con-
tributes to chromosome organization that supports the pluripo-
tency expression program in ESCs, including the expression of
Oct4 (Kagey et al., 2010; Nitzsche et al., 2011). Our data from
EpiSCs now suggest that cohesin variably participates in orga-
nizing chromatin at the Oct4 locus in ESCs and EpiSCs.
Knockdowns of only three genes showed an upregulation of
Oct4 expression in both cell types, reflecting the difference of
repressive Oct4 regulation in ESC and EpiSCs (category 5).
Overall, the RNAi screen provides a global view of Oct4 regu-
lators in EpiSCs and allows a comparison to genes influencing
Oct4 levels in ESCs.
Generation of an Oct4 Regulator E-MAP
RNAi screens can reveal the function for genes implicated in a
particular cellular process, but the interactions between the
different genes are usually not identified. Building a genetic epis-
tasis map (E-MAP) by perturbing pairs of genes is a powerful
approach for understanding functional relationships between
genes, including, but not limited to, physical interactions of their
gene products (Roguev et al., 2013). To obtain an E-MAP for 97
identified Oct4 regulators with strong phenotypes in EpiSCs, we
dispensed distinct esiRNAs in triplicate each into a 384-well cell
culture plate and overlaid these with a single constant esiRNA to
produce all pairwise combinations, resulting in 9,409 combina-
tions altogether. We then transfected OE7 EpiSCs with these
esiRNAmixtures and quantified GFP signals 72-hr post transfec-
tion by FACS (Figure 3A; Table S4). Genetic Interaction scores
(GIs) were calculated based on the phenotype strength (GFPCell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc. 143
Figure 2. Categorization of Validated Oct4
Modulators
(A) Phenotypic comparison of ESCs and EpiSCs.
Indicated categories classify the genes based
on their changes of Oct4 expression in ESCs and
EpiSCs. Knockdowns that upregulate Oct4 ex-
pression are shown in yellow. Knockdowns that
downregulate Oct4 expression are shown in blue.
The color intensity scales with the intensity of the
phenotype.
(B) Examples of knockdowns for different cate-
gories. Oct4 expression (green) after transfection
with indicated esiRNAs in ESCs and EpiSCs is
shown by immunostaining (upper) and quantified
by FACS (lower). DAPI was used to stain cell nuclei
(blue). Scale bars are 20 mm.intensities) using robust linear fitting to estimate the expected
double knockdown phenotypes (Figure S2). GIs were broadly
divided into three categories. First, there are synergistic interac-
tions (enhancements) whereby the resulting phenotype is stron-
ger than expected from the phenotypes associated with the
single knockdowns. These interactions are typically observed
in cases when the two factors act at the same step of a pathway
or in parallel (redundant) pathways. Second, there are buffering
interactions, where the compound phenotype is weaker than
anticipated. These interactions are often observed within linear144 Cell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc.pathways or between components of
protein complexes. Third, there are
neutral interactions, where the measured
phenotype is close to the expected.
Numerous buffering and synergistic GIs
were identified (Figure 3A; Table S4), indi-
cating complex connectivity of the factors
influencing Oct4 expression in EpiSCs.
To assess reliability of the data, we in-
spected the clustering of proteins forming
core complexes. Proteins from the same
complex typically have highly correlated
patters of genetic interactions and should
therefore cluster together within E-MAPs
(Roguev et al., 2013). Indeed, compo-
nents of known complexes, including
members of the Cnot, Cpsf, Paf1, Tip60,
and cohesin complexes, tightly clustered
together in the E-MAP of Oct4 regulators
in EpiSCs (Figure 3A).
Further support for high quality of the
data comes from the identification of
knownGIs. For example, Apc and Ctnnb1
(b-catenin) are both core components of
the Wnt signaling pathway. We measured
a strong buffering GI score for these two
factors (Figure 3B; Table S4), recapitu-
lating the known molecular pathway and
genetic interaction of Apc andCtnnb1 (Bi-
enz, 2002). Double knockdowns with sets
of independent esiRNAs for Apc and
Ctnnb1 showed that the GI profiles/Oct4expressions were highly consistent with those from the original
esiRNAs (Figure 3B), demonstrating high quality of the data
and signifying that the high specificity of esiRNAs (Kittler et al.,
2007) minimizes false positives for epistasis experiments (Ro-
guev et al., 2013).
Numerous additional measured GIs have not been described
previously and present valuable data to unravel the connectivity
of Oct4 modulators. For instance, we observed strong synergis-
tic interactions between bromodomain protein Brd4 and Myc-
circuitry components such as Max, Ep400, Tip60, and Trrap
Figure 3. Epistasis Map of Oct4 Modulators
(A) E-MAP profile of Oct4 modulators in EpiSCs.
GIs are illustrated as blue squares (negative GIs;
synergistic), yellow squares (positive GIs; buff-
ering), and black (neutral GIs). The numbers on the
color bar indicate GI scale. Proteins known to form
complexes are highlighted with a color code.
(B) Validation of the positive GI between Apc and
Ctnnb1 by quantitative western blot. Oct4 protein
levels were quantified and normalized to Gapdh
after treatment with indicated esiRNA combina-
tions. The non-targeting LUC esiRNA was used as
control. The numbers represent fold changes in
respect to LUC transfected cells.
(C) Validation of the negative GI between Brd4 and
Trrap by quantitative western blot. Oct4 protein
levels were quantified and normalized to Gapdh
after treatment with indicated esiRNA combina-
tions. The non-targeting LUC esiRNA was used as
control. The numbers represent fold changes in
respect to LUC transfected cells. Note the syner-
gistic upregulation of Oct4 after co-depletion of
Brd4 and Trrap.(Figure 3C; Table S4). Knockdown of Brd4, Max, Ep400, Tip60,
and Trrap alone led to an increase in Oct4 expression, suggest-
ing that these factors act as repressive regulators of Oct4 ex-
pression. As seen for other genes encoding proteins forming a
complex, the double knockdowns of the Myc-circuitry compo-
nents among themselves did not further increase expression
(e.g., weaker than expected phenotype) and showed a buffering
interaction (Figure 3C). In contrast, double knockdowns of Brd4
with Max, Ep400, Tip60, or Trrap led to a further increase (e.g.,
stronger phenotype) of Oct4 expression (Figure 3C), which man-
ifests itself as a synergistic interaction and points to Brd4 acting
independently and in parallel of the Myc circuitry in regulating
Oct4 expression in EpiSCs.
Altogether, the epistasis analysis of the selected 97 genes pro-
vides a genetic interactionmap of Oct4 regulators in EpiSCs. TheCell Systems 1, 141–151data should be helpful to decipher con-
nectivity and relations of the genetic
network regulating pluripotency.
BAC-TransgeneOmics and PLD
Molecular dissection of biological pro-
cessesbased onRNAi data alone remains
difficult. To extend the investigation, we
employed BAC transgenes expressing
GFP-tagged factors (Hofemeister et al.,
2011; Poser et al., 2008). In this approach,
candidate genes are GFP tagged on bac-
terial artificial chromosomes and stably
integrated into the genome of mammalian
cells in culture. Because the gene remains
in its genomic context, BAC tagging pro-
vides reliable and reproducible expres-
sion of the GFP-tagged protein at levels
and patterns matching those of the
endogenous counterpart (Poser et al.,
2008). From the 97 Oct4 regulators withstrong phenotypes, we were able to generate a panel of 36
BAC-tagged ESC and EpiSC lines and employed them for down-
stream analyses, including subcellular localization (Figure S3).
Technologies that measure global transcript changes after
RNAi have been widely employed to understand phenotypes
(e.g., Nishiyama et al., 2013). To systematically identify protein
level changes after RNAi, we utilized the panel of 36 BAC-tagged
EpiSCs and transfected them with an array of 36 corresponding
esiRNAs. Based on FACS quantification of the GFP-tagged pro-
teins, protein-level dependencies were calculated from changes
in fluorescence intensities compared to control transfected cells
(Figure 4A; Table S5). Effective protein depletion was measured
for esiRNAs that targeted the corresponding GFP-tagged tran-
script, validating the efficacy of the employed esiRNAs (Fig-
ure 4A; Table S5)., August 26, 2015 ª2015 Elsevier Inc. 145
Figure 4. PLD of Oct4 Modulators
(A) PLD matrix of Oct4 modulators. Protein-level
changes are illustrated for each cell line/esiRNA
combination with increases marked in yellow and
decreases marked in blue. The color intensities
scale with the intensity of the changed protein
level. Proteins known to form complexes are
highlighted with a color code.
(B) PLD between Cnot2 and Cnot3. Depletion of
Cnot3 leads to a decrease in Cnot2, whereas
depletion of Cnot2 results in an increased in Cnot3
(upper). Quantification of indicated mRNA levels
after Cnot2 knockdown are shown in the lower
panel. Error bars represent SD from triplicates.
Individual Z scores are shown in each square.
(C) PLD between Ctr9 and Cpsf3. Depletion of Ctr9
leads to a decrease in Cpsf3 and vice versa
(upper). Quantification of indicated mRNA levels
after Ctr9 knockdown is shown in the lower panel.
Error bars represent SD from triplicate samples.
Individual Z scores are shown in each square.
(D–G) FACS quantification of the expression
of BAC-tagged EpiSCs (left) or ESCs (right)
after transfection with indicated esiRNAs. The
tagged gene is presented in the respective Fl1
channels. The peaks show results after Luc
transfection (control; blue) and transfection with
indicated esiRNAs (red).On rare occasions, we observed that protein levels that
were not targeted by the esiRNA were altered, indicating that
the cells adjust the level of particular proteins, when another
protein is present at reduced levels. For 73 cases (5.6%), we
observed a significant negative PLD, where the amount of a pro-
tein was reduced together with the targeted protein (Figure 4A;
Table S5).
We frequently observed reduced protein levels for compo-
nents of a protein complex when one of the components was
knocked down, likely reflecting destabilization of the whole com-
plex when one component was missing (Theis et al., 2009). For
79 cases (6.1%), we detected a significant positive PLD, where
the amount of a protein increased when another protein was
depleted. However, unlike other protein complexes, Cnot3 pro-
tein levels markedly increased on knockdown of Cnot2. Cnot2146 Cell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc.and Cnot3 are core components of the
Ccr4-Not complex and together with
Cnot1 form a tight complex that is impor-
tant tomaintain ESC identity (Zheng et al.,
2012). To test whether the increased pro-
tein level of Cnot3 after Cnot2 RNAi is due
to transcriptional upregulation of Cnot3,
we performed RT-qPCR analyses after
knockdown of the components. Efficient
knockdown wasmeasured for thematch-
ing transcripts and esiRNAs, whereas
no significant change in transcription
was seen for Cnot3 after transfection
with esiRNA targeting Cnot2 (Figure 4B).
Therefore, the protein level changes
cannot be explained by transcriptional
changes, indicating that a post-transcrip-tional mechanism exists that leads to an increase in Cnot3 levels
when Cnot2 levels drop.
Many protein dependencies were also discovered for proteins
that do not tightly interact with each other. For instance, we
observed that the cleavage and polyadenylation specificity fac-
tor component Cpsf3 levels decreased significantly when the
Paf1C component Ctr9 was depleted (Figure 4C). Again, we
checked whether this co-regulation is caused by transcriptional
changes and found that transcript levels for Cpsf3 are not signif-
icantly altered after Ctr9 RNAi (Figure 4C). Hence, the protein
level dependency of Cpsf3 on Ctr9 must be post-transcription-
ally regulated.
These data validate the power of the innovative combination
between GFP-tagged BAC transgenesis and RNAi, which we
term PLD analysis. To investigate whether PLDs in EpiSCs
Figure 5. Multiparametric Integration of
Omics Data
(A) Graphical presentation of hierarchical cluster
analysis of indicated Omics data. A binary dis-
tance metric was used for the localization data,
and a Euclidean distance metric was employed for
all other datasets. Components of known protein
complexes are highlighted with the same color.
(B) Tox4 depletion decreases Oct4-GFP expres-
sion in ESCs and EpiSCs. Results from quan-
titative FACS analyses using two independent
esiRNAs (Tox4-1 and Tox4-2) and the luciferase
control esiRNAs (LUC) in Oct4-Gip ESCs and OE7
EpiSCs are shown. Values are means ± SD from
triplicate samples. ** indicates significance (p <
0.01) based on the Student’s t test.
(C) Phenotypic analysis of Tox4 knockdown
in ESCs and EpiSCs. The upper panel shows
brightfield microscopic images of EpiSCs treated
with indicated esiRNAs. Note the bigger and flatter
cells, loss of cell-to-cell contact, and failure to form
tight colonies in the Ctr9- and Tox4-transfected
cells. Scale bars are 50 mm. The lower panel shows
images of alkaline phosphatase stained ESCs after
transfection with indicated esiRNAs.
(D) Tox4 regulates the expression of developmental
genes. GeneOntology term analysis of differentially
regulated pathways after Tox4 knockdown is
shown. Fold enrichment of genes in each category
and p values are presented.are also observed in ESCs, we selected two negative PLDs
(Cnot2-Cnot3, Cpsf3-Ctr9) and two positive PLDs (Cnot2-
Fip1l1, Wdr82-Cnot2) and determined the dependencies in
ESCs. PLD patterns in ESCs were very similar to those observed
in EpiSCs (Figures 4D–4G), suggesting that the adjustment of
protein concentrations, at least for the tested cases, is con-
served in the two cell types.
Together, our data provide evidence that cells tune the amount
of proteins in relation to other proteins and that this tuning is, inCell Systems 1, 141–151the cases examined, controlled by post-
transcriptional regulation. Hence, our
data represent an additional layer of
Oct4 regulation exerted through finely
tuned protein levels for Oct4 modulators.
Integration of Omics Data
To integrate the datasets from the RNAi
screen, protein localization, E_MAP and
PLD analyses, we developed a multi-
parameter clustering strategy to system-
atically analyze candidate genes for
which all data were available (Figure 5A).
We performed hierarchical clustering
based on an average of scaled distance
matrices calculated for each data source
independently, employing a binary dis-
tance metric for the localization data
and a Euclidean distance metric for all
other datasets. A Gower’s coefficient (an
average of pairwise distances) was thenused to perform hierarchical agglomerative clustering (Kaufman
and Rousseeuw, 2009). Components of known complexes
closely clustered together in these analyses, suggesting that
this composite strategy can be applied to anatomize the re-
lationships of genes and to predict the functions of uncharac-
terized genes. Integrating multiple datasets is important: in-
specting the results from similar calculations where only two
datasets were used showed that protein complexes did not clus-
ter as robustly together, although some pairwise combinations, August 26, 2015 ª2015 Elsevier Inc. 147
Figure 6. Tox4 Physically Interacts with the
Paf1C
(A and B) Reciprocal Co-IPs of GFP-tagged Ctr9
and Tox4 in EpiSCs (A) and in ESCs (B) are shown.
The IP eluates and corresponding input were
probed with antibodies against Tox4, Ctr9, and
Gapdh. Gapdh served as a reference for Co-IP
enrichments. GFP-tagged Tox4 is marked by *,
and endogenous Tox4 is marked by X.
(C and D) Proteomic profiles of Tox4 and Ctr9 in-
teracting proteins. Results for indicated preys are
presented as volcano plots showing (log10 p
value) versus (log2 protein enrichment [GFP/WT]).
A hyperbolic curve (red lines, defined by threshold
value = 0.01 and S0 = 2) separates specific prey-
interacting proteins from background. Significant
enrichments of Paf1C core components are pre-
sented in orange. Bait proteins are highlighted in
bold.appeared to be more reliable than others (Figure S4). Overall,
the results indicate that multiparametric clustering is helpful
to formulate predictions for proteins that interact and that
increasing the number of independent datasets improves the
quality of the predictions. Previously we had identified a require-
ment for Paf1C to maintain Oct4 expression and ESC identity
(Ding et al., 2009). Our current screen revealed that Paf1C
components are also required for EpiSCs identity (Table S1).
The multiparameter clustering analysis placed Tox4 closely
together with Paf1C components Ctr9, Rtf1, and Wdr61 (Fig-
ure 5A), suggesting that Tox4 could function in a similar fashion.
Based on this finding, we selected Tox4 for more detailed func-
tional studies.
Tox4 Is Required for ESC and EpiSC Identity
Knockdown of Tox4 with two independent esiRNAs resulted in
decreased expression of Oct4 in both ESCs and EpiSCs (Figures148 Cell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc.5B and S1D). Furthermore, Tox4 and Ctr9
knockdown resulted in colonies with
reduced alkaline phosphatase activity, a
marker for pluripotency in ESCs and an
obvious differentiation phenotype in
EpiSCs, which was represented by bigger
and flatter cells, loss of cell-to-cell con-
tact and failure to form tight colonies
(Figure 5C). Furthermore, transcriptome
changes using RNA sequencing (RNA-
Seq) after Tox4 knockdown revealed a
significant enrichment for genes con-
nected to transcription and development
hierarchies, including organogenesis,
morphogenesis, pattern specification,
neurogenesis, cell differentiation, embry-
onic development, and cell-fate commit-
ment (Figure 5D; Table S6). Similar results
were obtained after Ctr9 knockdown
(Ding et al., 2009), consistent with func-
tional overlap of Tox4 and Ctr9. Taken
together, these results suggest thatTox4 knockdown promotes differentiation in both cell types, pre-
sumably through decreased expression of Oct4.
Tox4 Physically Interacts with Paf1C
To investigatewhether functional overlap between Tox4 andCtr9
is a result of a physical interaction between the two proteins, we
employed the BAC-tagged EpiSC lines and WT EpiSCs as con-
trols for co-immunoprecipitation (Co-IP) experiments. After affin-
ity purification with an anti-GFP antibody, prey proteins were
eluted and analyzed by western blot hybridization using anti-
Gapdh (control), anti-Tox4, and anti-Ctr9 antibodies (Figure 6A).
As expected, neither Ctr9 nor Tox4 could be detected in WT
EpiSCs IP samples. In contrast, the IP in the Tox4-GFP line prom-
inently pulled down Ctr9 protein, suggesting that these proteins
physically interact in EpiSCs. The IP also recovered both tagged
and untagged Tox4 protein, indicating that Tox4 is present in
a multimeric form. Likewise, Ctr9 and Tox4 were detected in
Ctr9-GFP IP samples, confirming physical interaction between
Ctr9 and Tox4 in EpiSCs (Figure 6A). To determine whether this
interaction can also be detected in ESCs, we repeated the Co-
IPs using Tox4 andCtr9GFP-taggedESCs.Resultswere virtually
identical (Figure 6B), suggesting a robust interaction of Tox4
and Ctr9 in pluripotent cells. To further validate the interaction
between Tox4 and Ctr9 and to investigate whether Tox4 also
interacts with other Paf1C components, we analyzed the Co-IP
eluates by mass spectrometry. Consistent with the western blot
hybridizations, the proteomic profile of Tox4 IP revealed a
prominent interaction with Ctr9. In addition, other core compo-
nents of the Paf1C, including Paf1, Cdc73, and Leo1, were also
readily identified (Figure 6C; Table S7). Furthermore, the Ctr9 IP
profile unmasked the canonical Paf1C components Paf1, Leo1,
Wdr61, Ctr9, and Cdc73 in addition to Tox4 (Figure 6D; Table
S7), demonstrating that Tox4 indeed physically interacts with
Paf1C. Together, our proteomic and phenotypic data establishes
Tox4 as a new interaction partner of the Paf1 complex in ESCs
and EpiSCs that shares functional roles in Oct4 regulation,
necessary to maintain ESC and EpiSC identity.
DISCUSSION
While the regulation of pluripotency in ESCs has been studied
intensively, the mechanisms that regulate EpiSCs pluripotency
are largely unexplored. To close this gap, we present results
from a genome-scale RNAi screen for Oct4 regulators in mouse
EpiSCs. We observe that knockdown of numerous genes has
similar effects on Oct4 expression in ESCs and EpiSCs. How-
ever, others have different or even opposite effects, reflecting
the divergent regulation of Oct4 in these two cell types. In
contrast to ESCs, the Oct4 gene is under repressive control in
EpiSCs. This finding argues for a fundamental switch of Oct4
regulation during the transition from pre-implantation to post-im-
plantation. It will be interesting to investigate this switch in the
future and relate it to the already known differences in Oct4
enhancer activities in ESCs versus EpiSCs (Tesar et al., 2007;
Yeom et al., 1996).
To go beyond a simple description of gene lists, we comple-
ment the RNAi screen with localization, genetic interaction,
PLD, and proteomic studies and show how meaningful data
can be extracted from the various -omics analyses and how test-
able hypotheses can be formulated from these data. Therefore,
our data provide starting points to unravel a variety of mecha-
nisms supporting pluripotency.
The GI investigations should be helpful in resolving how the
network of Oct4 modulators governs the pluripotency versus dif-
ferentiation decision in EpiSCs. For instance, the identified GIs
between Brd4 and components of the Myc-module represent
an informative epistasis example. Both Brd4 and the Myc-mod-
ule components Max, Ep400, Tip60, and Trrap are Oct4 repres-
sors in EpiSCs, which synergize to enhance Oct4 expression
when depleted together. The Myc-module comprises various
members of the NuA4 histone acetyltransferase complex (Kim
et al., 2010), possibly implicating histone acetylation for Oct4
repression in EpiSCs. Brd4 is an epigenetic regulator that binds
acetylated histones (Dey et al., 2003), providing a possible ex-
planation for the enhanced Oct4 expression. How Brd4 mecha-
nistically synergizes with the Myc-module to repress Oct4 inEpiSCs and how and why this regulation is different in ESCs
require further investigation.
PLD mapping reveals unexpected regulation at the protein
level. Knowing how the concentrations of key proteins are
dependent on the activities of separate genes may provide one
key to understanding cellular behavior at a systems level. Pro-
tein-level adjustments via transcriptional changes have been
studied to some extent, and RNA-Seq is now widely used to
investigate transcriptome changes following perturbations
(Nishiyama et al., 2013). However, many protein-level adjust-
ments appear to be post-transcriptionally regulated. It will there-
fore be important to develop appropriate high-throughput
methods to investigate processes such as RNA splicing, protein
translation, post-translational modifications, and protein degra-
dation to better understand how concentrations of proteins are
adjusted in cells. In the meantime, PLDmapping should be help-
ful to complement other -omics technologies in systems-level
analyses of biological processes.
As useful as individual -omics data are to characterize certain
biological processes, they often have limited utility when it
comes to a deeper understanding of a system. The integration
of multidimensional data types is challenging, as is anchoring
them in directly testable hypotheses (Cornish and Markowetz,
2014; Flintoft, 2014; Payne, 2012). This study provides one
approach to overcoming this hurdle and illuminates new features
of pluripotency.
The combined analyses of the employed assays suggested
similarity of Tox4 with proteins of the Paf1C. We and others
have previously shown that Paf1C has essential roles in main-
taining ESC pluripotency and regulating the expression of genes
involved in lineage specification, including Oct4 (Ding et al.,
2009; Zhang et al., 2013). Our phenotypic and proteomic data
indeed classify Tox4 as a newprotein required tomaintain plurip-
otency through physical interaction with Paf1C. How exactly
Tox4 collaborates with the Paf1C to regulate Oct4 expression
and possibly other pluripotency factors at the molecular level
will have to be investigated.
The collective analysis of RNAi screening data with protein
localization has previously been demonstrated to provide the
predictive power to identify new core components of a protein
complex (Theis et al., 2009). Our data from this study indicates
that this combination is also useful to predict interacting proteins
that are not part of the core complex (Figure S4). Hence, the
combination of these two datasets seems particularly well suited
for multiparametric data analyses, possibly because of the an-
tagonal nature of the two datasets. However, the integration of
these data with GI and PLD data improves the prediction (Fig-
ure 5A), arguing that complementation of different datasets
further enhances the quality of the data. Future studies in this di-
rection should be helpful to extend meta-analysis approaches to
various -omics datasets, in particular to refine data mining algo-
rithms by optimizing their ability of detecting true relationships
between biological entities.EXPERIMENTAL PROCEDURES
General Methods
Recombineering, gene targeting, bacterial artificial chromosome (BAC)
transgenesis, and Co-IPs using the GFP tag were performed as previouslyCell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc. 149
described (Denissov et al., 2014; Poser et al., 2008). Sequences of primers
used in this study are provided in Table S8.
Mouse EsiRNA Library
EsiRNAs were synthesized as described previously (Kittler et al., 2005) and
normalized to 100 ng/ml in 384-well plates for the genome-scale screen. A
complete list of employed esiRNAs is provided in Table S1.
Cell Culture and High-Throughput Screen
ESCs were maintained in Glasgow Minimum Essential Medium (GMEM), sup-
plemented with 10% fetal bovine serum (FBS) and leukemia inhibitory factor
(LIF). EpiSCs were cultured in N2B27 medium supplemented with Activin A
and Fgf2.
For the genome-scale screen, EpiSCs were reverse-transfected in fibro-
nectin-coated 384-well plates using Lipofectamine 2000 (Invitrogen). GFP
fluorescence and cell numbers were measured 72-hr post-transfection using
a FACSCalibur (BD biosciences) equipped with a high-throughput sampler
(HTS) loader for high-throughput analysis. Full details are provided in the Sup-
plemental Information.
Epistasis Analysis
Pair-wise esiRNA matrix (25 ng esiRNA(A) and 25 ng esiRNA(B) in 10 ml
OptiMEM medium) was pipetted onto fibronectin-coated 384-well plates.
OE7 EpiSCs were reverse transfected using Lipofectaime 2000 (Invitrogen)
in triplicates for each combination. Oct4 expression was quantified 72-hr
post-transfection using a FACSCalibur (BD Biosciences) equipped with an
HTS loader. Raw data were normalized to the median value of the GFP signal,
and the resulting distribution was centered over zero. Phenotypes emerging
from individual RNAi knockdowns were defined for each gene as the median
of the normalized GFP signal distribution for all gene pairs containing the
gene of interest. For each set of double RNAi combinations containing a partic-
ular gene, a linear model describing the relationship between the single RNAi
phenotypes and the phenotypes observed upon double RNAi knockdown
(e.g., D = a*S + b, where D is the phenotype upon double RNAi, S is the
computed single RNAi effect, a is the slope of the fit, and b is the y intercept)
was computed using a robust linear-fitting algorithm minimizing the effect of
the outliers. The y intercepts of these models represent the phenotypes from
single RNAi knockdown for each gene and are in very good agreement with
the computed single RNAi phenotypes. Genetic interaction scores for each
RNAi pairwise combination are defined as the residuals of that fit.
Immunofluorescence
EpiScs and ESCs were fixed with 4% paraformaldehyde in PBS. After perme-
abilization in 1% Triton X-100/PBS for 30 min, immunostaining was performed
using the following primary antibodies: Oct4 (Santa Cruz Biotechnology, Cat#
sc-8628, RRID: AB_653551), alpha-Tubulin (Abcam, Cat# ab15246, RRID:
AB_301787), and GFP (MPI-CBG, protein facility). Secondary antibodies
used were Alexa Fluor 488/594 anti-mouse IgG, anti-rabbit, or anti-goat IgG
(Invitrogen). DAPI (Invitrogen) was used for staining the nuclei. Images were
taken using a DeltaVision microscopy imaging system (GE Life Sciences).
Co-IP
GFP-tagged protein complexes were isolated by immunoaffinity chromatog-
raphy using a polyclonal goat anti-GFP antibody that was generated in house
as previously described (Poser et al., 2008) and analyzed by mass spectrom-
etry or western hybridization using the following primary antibodies: Ctr9
(Abcam, Cat# ab84487, RRID: AB_1860992), Tox4 (Sigma-Aldrich, Cat#
HPA017880, RRID: AB_1845573), and Gapdh (Novus Biologicals, Cat#
NB300-221, RRID: AB_10077627). See Supplemental Information for details.
RNA Sequencing
1.5 3 105 EpiSCs cells were reverse transfected with 1,000 ng Luc and Tox4
esiRNAs and 2 ml lipofectamine 2000 in fibronectin-coated 6-well plates. At
72-hr post-transfection, total RNA was isolated using the RNeasy Mini kit
(QIAGEN); poly(A) fractions were purified by double selection on oligo(dT)
beads, and cDNA was prepared as described previously (Marks et al., 2012).
Sequencing libraries for cDNA samples were prepared using Illumina kits
and processed on Illumina HiSeq 2000. Base calling was performed with Illu-150 Cell Systems 1, 141–151, August 26, 2015 ª2015 Elsevier Inc.mina CASAVA-1.8.0. RNA-Seq aligner STAR-2.3.0e (Dobin et al., 2013) was
used to map sequencing reads to mm10 (Mus musculus, Dec. 2011) genome
assembly. Gene expression was calculated as a number of reads per 1 kb of a
mappable portion of a gene (evaluated by presence of sequencing reads) and
normalized to 1 million reads in a sample Gene ontology (GO) and pathway an-
alyses were performed using DAVID (https://david.abcc.ncifcrf.gov).
ACCESSION NUMBERS
RNA-Seq data can be found on the public server Gene Expression Omnibus
(GEO) under the accession number of GEO: GSE62357. Further details are
available in Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and eight tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cels.2015.08.002.
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